文獻分享：異核復合物具有抗轉移和抗血管生成活性
文獻摘要
4.1. Materials and methods
RuCl3·nH2O (J&K), bpy (J&K), phen (J&K), DIP (J&K), 5,6-diamino-1,10-phenanthroline (Alfa Aesar), 1,10-phenanthroline-5,6-dione (Alfa Aesar), Re(CO)5Cl (Sigma Aldrich), NH4PF6 (Alfa Aesar), DPBF (Alfa Aesar), MB (Alfa Aesar), Dulbecco's Modified Eagle Medium (DMEM, Gibco), Roswell Park Memorial Institute 1640 (RPMI 1640, Gibco), fetal bovine serum (Gibco), penicillin-streptomycin (Gibco), MTT (J&K), JC-1 Detection Kit (Beyotime), H2DCFDA (J&K), Hoechst 33342 (J&K), Annexin V-FITC Apoptosis Detection Kit (Beyotime), Matrigengel (ABW). Primary antibodies against caspase-3, PARP, MMP-2, MMP-9 and VEGFR2 were purchased from Cell Signaling Technology. RuRe1–3 were dissolved in DMSO (1%, v/v) just before the biological experiments.
發表時間：2022年12月1日
IF：4.336
文章引用產品：MG&ABW Matrigengel
作者單位：
昆明理工大學生命科學與技術學院
云南師范大學化學化工學院
原文鏈接：
https://doi.org/10.1016/j.jinorgbio.2022.112090（需復制到網頁查看）
以下為引用�；ˋBW）基質膠文獻
